wsbdaily | Tue, 20 Dec 2022 03:11:28 EST Where you find Tomorrow’s Hot Stocks Yesterday!
NOT INVESTMENT ADVICE: ALL CONTENT IS PROVIDED 'AS IS' FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.
Tricida, Inc.(TCDA)
Tricida, Inc.
7000 Shoreline Court
Suite 201
South San Francisco, CA 94080
United States
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
Summary & Charts
| Price | $ 0.16 | -0.01 (-5.89%) |
| Day's Range | $ 0.15 - 0.17 | |
| Previous Close | $ 0.17 | |
| Market Cap | $ 13.8M USD | |
| Short Interest % | 46.63 % | As of Fri, 14 Jan 2022 |
| Float | 31.4M | |
| Outstanding | 58.03M |
| Exchange | NasdaqGS | |
| Industry | Biotechnology | |
| Sector | Healthcare | |
| Volume | 4.90M | |
| Avg. Volume (20 day) | 12.37M | |
| Rel. Volume (20 day) | 0.40 | |
| Rel. Volume (3 month) | 0.45 | |
| Rating | B- | Neutral |
| DCF | N/A | Strong Buy |
| Debt/Equity | -168.98 % | Sell |
| ROE | 158.76 % | Buy |
| ROA | -142.64 % | Sell |
| P/E | -0.05 % | Strong Sell |
| P/B | -0.07 % | Strong Sell |
| Date | Open | High | Low | Close | Change | Volume | R. Vol. (20d) | R. Vol. (3m) | Mentions |
|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2022 | $ 0.17 | $ 0.17 | $ 0.15 | $ 0.16 | -0.01 | 4,903,218 | 0.40 | 0.45 | 1 |
| Dec 16, 2022 | $ 0.15 | $ 0.19 | $ 0.15 | $ 0.17 | +0.02 | 8,562,741 | 0.69 | 0.79 | |
| Dec 15, 2022 | $ 0.16 | $ 0.16 | $ 0.15 | $ 0.15 | -0.01 | 4,511,507 | 0.37 | 0.43 | |
| Dec 14, 2022 | $ 0.17 | $ 0.18 | $ 0.16 | $ 0.16 | -0.02 | 8,592,976 | 0.70 | 0.83 | |
| Dec 13, 2022 | $ 0.20 | $ 0.21 | $ 0.17 | $ 0.17 | -0.03 | 13,569,834 | 1.09 | 1.35 | |
| Dec 12, 2022 | $ 0.21 | $ 0.22 | $ 0.20 | $ 0.21 | -0.01 | 5,638,066 | 0.45 | 0.58 | |
| Dec 09, 2022 | $ 0.24 | $ 0.25 | $ 0.21 | $ 0.22 | -0.02 | 8,419,997 | 0.63 | 0.89 | |
| Dec 08, 2022 | $ 0.24 | $ 0.27 | $ 0.23 | $ 0.24 | -0.00 | 8,895,809 | 0.66 | 0.96 | 1 |
| Dec 07, 2022 | $ 0.22 | $ 0.24 | $ 0.21 | $ 0.24 | +0.02 | 4,134,618 | 0.30 | 0.46 | |
| Dec 06, 2022 | $ 0.23 | $ 0.23 | $ 0.21 | $ 0.22 | -0.01 | 4,337,304 | 0.31 | 0.49 | |
| Dec 05, 2022 | $ 0.25 | $ 0.25 | $ 0.22 | $ 0.23 | -0.02 | 6,142,279 | 0.43 | 0.71 | |
| Dec 02, 2022 | $ 0.25 | $ 0.26 | $ 0.23 | $ 0.25 | -0.00 | 4,819,335 | 0.32 | 0.55 | |
| Dec 01, 2022 | $ 0.24 | $ 0.25 | $ 0.23 | $ 0.25 | +0.01 | 7,164,270 | 0.47 | 0.82 | |
| Nov 30, 2022 | $ 0.27 | $ 0.27 | $ 0.22 | $ 0.24 | -0.03 | 17,265,965 | 1.09 | 1.96 | |
| Nov 29, 2022 | $ 0.29 | $ 0.29 | $ 0.24 | $ 0.27 | -0.01 | 20,235,834 | 1.24 | 2.33 | 3 |
| Nov 28, 2022 | $ 0.22 | $ 0.30 | $ 0.22 | $ 0.28 | +0.08 | 47,987,163 | 2.88 | 5.63 | 9 |
| Nov 25, 2022 | $ 0.19 | $ 0.25 | $ 0.19 | $ 0.21 | +0.01 | 29,399,484 | 1.95 | 3.70 | 2 |
| Nov 23, 2022 | $ 0.23 | $ 0.27 | $ 0.19 | $ 0.19 | -0.04 | 28,568,416 | 1.89 | 3.75 | |
| Nov 22, 2022 | $ 0.23 | $ 0.27 | $ 0.23 | $ 0.23 | +0.00 | 8,499,552 | 0.54 | 1.16 | |
| Nov 21, 2022 | $ 0.25 | $ 0.25 | $ 0.23 | $ 0.23 | -0.02 | 5,698,225 | 0.34 | 0.78 |
News
The latest news about Tricida, Inc. (TCDA).
Finbold | 2022-11-30 11:18:05
The difficult state of the macroeconomic environment in 2022 has had a negative impact on the performance of a number of equity investments. Worries about a recession and a bearish attitude among investors have been especially unsettling for companies with weak financial positions.
PennyStocks | 2022-11-08 06:00:00
Trading under $1 penny stocks? Use these tips The post What to Look For in Penny Stocks Under $1, 3 Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
PennyStocks | 2022-11-07 06:00:00
Check these tips out for trading penny stocks right now The post Buying Cheap Penny Stocks in November? 3 Tips to Use appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
InvestorPlace | 2022-10-24 11:18:11
Tricida (NASDAQ: TCDA ) stock is falling on Monday following the release of poor results from a Phase 3 clinical trial. That trial covers the use of veverimer to treat patients suffering from metabolic acidosis and chronic kidney disease (CKD).
Earnings
| Date | Time | EPS Expected | EPS Reported | % | Revenue Expected | Revenue Reported | % |
|---|---|---|---|---|---|---|---|
| 2022-11-14 | AMC | -0.54 | -0.44 | 18.52% | -- | -- | -- |
| 2022-08-08 | AMC | -0.58 | -0.49 | 15.52% | -- | -- | -- |
| 2022-05-10 | AMC | -0.7 | -- | -- | -- | -- | -- |
| 2022-03-29 | AMC | -0.68 | -0.92 | 35.29% | -- | -- | -- |
| 2021-11-08 | AMC | -0.69 | -0.79 | 14.49% | -- | -- | -- |
| 2021-08-09 | AMC | -0.72 | -0.67 | 6.95% | -- | -- | -- |
| 2021-05-06 | AMC | -1.03 | -1.06 | 2.91% | -- | -- | -- |
| 2021-02-25 | AMC | -1.12 | -1.09 | 2.68% | -- | -- | -- |
Top Discussions
These are the top discussions over the last 24-hours that mention the TCDA stock ticker symbol.
Daily Plays December 19, 2022
Talk about your plays today or things you are on the lookout for. This is where you belong if your comment includes a $Ticker in that format. ​ *keep it civil please*...
Daily Plays December 18, 2022
Talk about your plays today or things you are on the lookout for. This is where you belong if your comment includes a $Ticker in that format. ​ *keep it civil please*...
- (2 points) TCDA
Failures to Deliver
Each point represents the aggregate net balance of shares that failed to be delivered as of a particular settlement date.
Please note that fails-to-deliver can occur for a number of reasons on both long and short sales. Therefore, fails-to-deliver are not necessarily the result of short selling, nor evidence of abusive “naked” short selling. For more information on short selling and fails-to-deliver, see Key Points About Regulation SHO, Division of Market Regulation, and Final Rule: Short Sales.
Last Updated: Mon, 13 Dec 2021 12:00 EST
@wsbdaily
wsbdaily